WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 232
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 282

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 270  265  259  253  247  185  147  116 
Births
Surviving infants
Pop. less than 5 years 34  35  35  35  36  28  24  19 
Pop. less than 15 years 98  97  95  94  93  77  64  51 
Female 15-49 years 68  66  65  64  62  45  34  26 

Number of reported cases

(Click for retrospective incidence data for Vanuatu)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  39  10  67  39 
Mumps
ChartChart
 
Pertussis
ChartChart
  36  231 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Vanuatu)
Vaccine year result method % card seen                                                
BCG 2012  73  DHS   57  94  95  95  89  99*  99  96 
DTP1 2012  76  DHS   57  94  90  95  87  99* 
DTP3 2012  55  DHS   57  81  80  86  75  95  90  76 
DTP4         
IPV1          63 
HepB_BD          71  80  80  76  79 
HepB3 2012  55  DHS   57  81  80  86  75  95  75 
Hib3 2012  55  DHS   57  81  80  86  75  95 
JapEnc         
MCV1          84  76  90  65  94  94  66 
MCV2         
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2012  52  DHS   57  81  80  80  75  95  87  78 
Rota1         
RotaC         
RCV1          84 
TT2plus 2012  30  DHS   57  60  99*  25  88  43 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Vanuatu)
BCG
ChartChart
  73  73  73  73  73  79  96 
DTP1
ChartChart
  75  75  75  75  75  85  91 
DTP3
ChartChart
  64  64  64  64  64  71  76 
HepB3
ChartChart
  64  64  64  64  64  70 
HepB_BD
ChartChart
 
Hib3
ChartChart
  64  64  64  64  64 
IPV1
  50 
MCV1
ChartChart
  53  53  53  53  53  61  66 
MCV2
ChartChart
 
PCV3
 
Pol3
ChartChart
  65  65  65  65  65  67  78 
RCV1
ChartChart
  53  53 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 33
From 50 to 79% 67
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes
IPV 14 weeks; Yes
MR 12 months;
OPV 6, 10, 14 weeks; 6, 12 years; Yes
Td 6, 12 years; Yes
TT 1st contact; +2, +6 months; +1, +2 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number       5yrs    2010-2015  2010-2014 
Nº of districts with microplans that include activities to raise immunization coverage number  

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 33  33  67  17  83  67  67 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 33  33   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No    No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No    No  Yes  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 17  25    80    6'000 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.